Coronary Heart Disease (CHD)
Cardiovascular·MeSH: Coronary Disease
Prevalence
3103.7 / 100K
Incidence
164.9 / 100K/yr
3 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| pravastatin | Aptinyx Inc. (APTX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Coronary Heart Disease (CHD)?
BioSniper tracks 3 drugs in development for Coronary Heart Disease (CHD) across 2 companies.
How many clinical trials target Coronary Heart Disease (CHD)?
There are 1 clinical trial targeting Coronary Heart Disease (CHD) tracked by BioSniper.
What is the prevalence of Coronary Heart Disease (CHD)?
The estimated prevalence of Coronary Heart Disease (CHD) is approximately 3103.7 per 100,000 population.
Deep-dive into Coronary Heart Disease (CHD)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis